Muscle inflammatory signaling in response to 9 days of physical inactivity in young men with low compared with normal birth weight

European Journal of Endocrinology

Volumn 167, Issue 6, 2012, Pages 829-838

  Friedrichsen, Martin ^a,b   Ribel Madsen, Rasmus ^a   Mortensen, Brynjulf ^a   Hansen, Christina N ^b   Alibegovic, Amra C ^a   Højbjerre, Lise ^b   Sonne, Mette P ^b   Wojtaszewski, Jørgen F P ^b   Stallknecht, Bente ^b   Dela, Flemming ^b   Vaag, Allan ^a,c  

^a STENO DIABETES CENTER   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CD68 ANTIGEN; CYTOCHROME C OXIDASE; CYTOCHROME C OXIDASE POLYPEPTIDE 7A1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INTERLEUKIN 6; MEMBRANE PROTEIN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE SUBUNIT O; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE 1 BETA SUBCOMPLEX SUBUNIT 6; UBIQUINOL CYTOCHROME C REDUCTASE BINDING PROTEIN; UNCLASSIFIED DRUG;

ACCURACY; ADULT; ANTIGEN EXPRESSION; ARTICLE; BED REST; CELL INFILTRATION; CONTROLLED STUDY; DIABETES MELLITUS; GENE EXPRESSION; GLUCOSE CLAMP TECHNIQUE; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LOW BIRTH WEIGHT; MACROPHAGE; MALE; MUSCLE BIOPSY; MYOSITIS; OXIDATIVE PHOSPHORYLATION; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ADULT; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CARRIER PROTEINS; CHEMOKINE CCL2; ELECTRON TRANSPORT COMPLEX IV; GLUCOSE CLAMP TECHNIQUE; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INTERLEUKIN-6; MALE; MUSCLE, SKELETAL; NADH, NADPH OXIDOREDUCTASES; NF-KAPPA B; REST; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 84869047797     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-12-0498     Document Type: Article

References (54)

1. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988 37 1595-1607. (doi:10.2337/diabetes.37.12.1595)
2. Mayer EJ, Newman B, Austin MA, Zhang D, Quesenberry CP Jr, Edwards K & Selby JV. Genetic and environmental influences on insulin levels and the insulin resistance syndrome: an analysis of women twins. American Journal of Epidemiology 1996 143 323-332. (doi:10.1093/oxfordjournals.aje.a008746)
3. Poulsen P, Kyvik KO, Vaag A & Beck-Nielsen H. Heritability of type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance - a population-based twin study. Diabetologia 1999 42 139-145. (doi:10.1007/ s001250051131)
4. DeFronzo RA. Glucose intolerance and aging. Diabetes Care 1981 4 493-501. (doi:10.2337/diacare.4.4.493)
5. Yki-Jarvinen H. Sex and insulin sensitivity. Metabolism 1984 33 1011-1015. (doi:10.1016/0026-0495(84)90229-4)
6. Ferrannini E. Physiological and metabolic consequences of obesity. Metabolism 1995 44 15-17. (doi:10.1016/0026-0495(95)90313-5)
7. Soman VR, Koivisto VA, Deibert D, Felig P & DeFronzo RA. Increased insulin sensitivity and insulin binding to monocytes after physical training. New England Journal of Medicine 1979 301 1200-1204. (doi:10.1056/ NEJM197911293012203)
8. Jensen CB, Storgaard H, Dela F, Holst JJ, Madsbad S & Vaag AA. Early differential defects of insulin secretion and action in 19-year-old Caucasian men who had low birth weight. Diabetes 2002 51 1271-1280. (doi:10.2337/diabetes. 51.4.1271)
9. Hales CN, Barker DJ, Clark PM, Cox LJ, Fall C, Osmond C &Winter PD. Fetal and infant growth and impaired glucose tolerance at age 64. BMJ 1991 303 1019-1022. (doi:10.1136/bmj.303.6809.1019)
10. Poulsen P, Levin K, Beck-Nielsen H & Vaag A. Age-dependent impact of zygosity and birth weight on insulin secretion and insulin action in twins. Diabetologia 2002 45 1649-1657. (doi:10.1007/s00125-002-0983-6)
11. Brons C, Jacobsen S, Nilsson E, Ronn T, Jensen CB, Storgaard H, Poulsen P, Groop L, Ling C, Astrup A & Vaag A. Deoxyribonucleic acid methylation and gene expression of PPARGC1A in human muscle is influenced by high-fat overfeeding in a birth-weight-dependent manner. Journal of Clinical Endocrinology and Metabolism 2010 95 3048-3056. (doi:10.1210/jc.2009-2413)
12. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS &Marks JS. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. Journal of the American Medical Association 2003 289 76-79. (doi:10.1001/jama.289.1.76)
13. Kolb H & Mandrup-Poulsen T. The global diabetes epidemic as a consequence of lifestyle-induced low-grade inflammation. Diabetologia 2010 53 10-20. (doi:10.1007/s00125-009-1573-7)
14. Slentz CA, Houmard JA & Kraus WE. Exercise, abdominal obesity, skeletal muscle, and metabolic risk: evidence for a dose response. Obesity 2009 17 (Suppl 3) S27-S33. (doi:10.1038/oby.2009.385)
15. Thyfault JP & Booth FW. Lack of regular physical exercise or too much inactivity. Current Opinion in Clinical Nutrition and Metabolic Care 2011 14 374-378. (doi:10.1097/MCO.0b013e3283468e69)
16. Pedersen BK. The diseasome of physical inactivity - and the role of myokines in muscle - fat cross talk. Journal of Physiology 2009 587 5559-5568. (doi:10.1113/jphysiol.2009.179515)
17. Alibegovic AC, Sonne MP, Hojbjerre L, Bork-Jensen J, Jacobsen S, Nilsson E, Faerch K, Hiscock N, Mortensen B, Friedrichsen M, Stallknecht B, Dela F & Vaag A. Insulin resistance induced by physical inactivity is associated with multiple transcriptional changes in skeletal muscle in young men. American Journal of Physiology. Endocrinology and Metabolism 2010 299 E752-E763. (doi:10.1152/ajpendo.00590.2009)
18. Sriwijitkamol A, Christ-Roberts C, Berria R, Eagan P, Pratipanawatr T, DeFronzo RA, Mandarino LJ & Musi N. Reduced skeletal muscle inhibitor of κB β content is associated with insulin resistance in subjects with type 2 diabetes: reversal by exercise training. Diabetes 2006 55 760-767. (doi:10.2337/diabetes.55.03.06.db05-0677)
19. Herder C, Peltonen M, Koenig W, Sutfels K, Lindstrom J, Martin S, Ilanne-Parikka P, Eriksson JG, Aunola S, Keinanen-Kiukaanniemi S, Valle TT, Uusitupa M, Kolb H & Tuomilehto J. Anti-inflammatory effect of lifestyle changes in the Finnish Diabetes Prevention Study. Diabetologia 2009 52 433-442. (doi:10.1007/s00125-008-1243-1)
20. Petersen AM & Pedersen BK. The anti-inflammatory effect of exercise. Journal of Applied Physiology 2005 98 1154-1162. (doi:10.1152/japplphysiol. 00164.2004)
21. Hamer M. The relative influences of fitness and fatness on inflammatory factors. Preventive Medicine 2007 44 3-11. (doi:10.1016/j.ypmed.2006.09.005)
22. Fleischman A, Shoelson SE, Bernier R & Goldfine AB. Salsalate improves glycemia and inflammatory parameters in obese young adults. Diabetes Care 2008 31 289-294. (doi:10.2337/dc07-1338)
23. Yuan M, Konstantopoulos N, Lee J, Hansen L, Li ZW, Karin M &Shoelson SE. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkß. Science 2001 293 1673-1677. (doi:10.1126/science.1061620)
24. Cai D, Frantz JD, Tawa NE Jr, Melendez PA, Oh BC, Lidov HG, Hasselgren PO, Frontera WR, Lee J, Glass DJ & Shoelson SE. IKKβ/NF-κB activation causes severe muscle wasting in mice. Cell 2004 119 285-298. (doi:10.1016/j.cell.2004.09.027)
25. Friedrichsen M, Ribel-Madsen R, Wojtaszewski J, Grunnet L, Richter EA, Billestrup N, Ploug T, Vaag A & Poulsen P. Dissociation between skeletal muscle inhibitor-κB kinase/nuclear factor-κB pathway activity and insulin sensitivity in nondiabetic twins. Journal of Clinical Endocrinology and Metabolism 2010 95 414-421. (doi:10.1210/jc.2009-1147)
26. Austin RL, Rune A, Bouzakri K, Zierath JR & Krook A. siRNA-mediated reduction of inhibitor of nuclear factor-κB kinase prevents tumor necrosis factor-α-induced insulin resistance in human skeletal muscle. Diabetes 2008 57 2066-2073. (doi:10.2337/db07-0763)
27. Sinha S, Perdomo G, Brown NF & O'Doherty RM. Fatty acid-induced insulin resistance in L6 myotubes is prevented by inhibition of activation and nuclear localization of nuclear factor κB. Journal of Biological Chemistry 2004 279 41294-41301. (doi:10.1074/jbc.M406514200)
28. Tantiwong P, Shanmugasundaram K, Monroy A, Ghosh S, Li M, DeFronzo RA, Cersosimo E, Sriwijitkamol A, Mohan S & Musi N. NF-κB activity in muscle from obese and type 2 diabetic subjects under basal and exercise-stimulated conditions. American Journal of Physiology. Endocrinology and Metabolism 2010 299 E794-E801. (doi:10.1152/ajpendo.00776.2009)
29. Marette A. Mediators of cytokine-induced insulin resistance in obesity and other inflammatory settings. Current Opinion in Clinical Nutrition and Metabolic Care 2002 5 377-383. (doi:10.1097/00075197-200207000-00005)
30. Pahl HL. Activators and target genes of Rel/NF-κB transcription factors. Oncogene 1999 18 6853-6866. (doi:10.1038/sj.onc.1203239)
31. Ueda A, Okuda K, Ohno S, Shirai A, Igarashi T, Matsunaga K, Fukushima J, Kawamoto S, Ishigatsubo Y & Okubo T. NF-κB and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene. Journal of Immunology 1994 153 2052-2063.
32. Kobara M, Sunagawa N, Abe M, Tanaka N, Toba H, Hayashi H, Keira N, Tatsumi T, Matsubara H & Nakata T. Apoptotic myocytes generate monocyte chemoattractant protein-1 and mediate macrophage recruitment. Journal of Applied Physiology 2008 104 601-609. (doi:10.1152/japplphysiol.00254.2007)
33. Sell H, Dietze-Schroeder D, Kaiser U & Eckel J. Monocyte chemotactic protein-1 is a potential player in the negative cross-talk between adipose tissue and skeletal muscle. Endocrinology 2006 147 2458-2467. (doi:10.1210/en.2005-0969)
34. Kamei N, Tobe K, Suzuki R, Ohsugi M, Watanabe T, Kubota N, Ohtsuka-Kowatari N, Kumagai K, Sakamoto K, Kobayashi M, Yamauchi T, Ueki K, Oishi Y, Nishimura S, Manabe I, Hashimoto H, Ohnishi Y, Ogata H, Tokuyama K, Tsunoda M, Ide T, Murakami K, Nagai R & Kadowaki T. Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. Journal of Biological Chemistry 2006 281 26602-26614. (doi:10.1074/jbc.M601284200)
35. Hong EG, Ko HJ, Cho YR, Kim HJ, Ma Z, Yu TY, Friedline RH, Kurt-Jones E, Finberg R, Fischer MA, Granger EL, Norbury CC, Hauschka SD, Philbrick WM, Lee CG, Elias JA & Kim JK. Interleukin-10 prevents diet-induced insulin resistance by attenuating macrophage and cytokine response in skeletal muscle. Diabetes 2009 58 2525-2535. (doi:10.2337/db08-1261)
36. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL &Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. Journal of Clinical Investigation 2003 112 1796-1808.
37. Nguyen MT, Favelyukis S, Nguyen AK, Reichart D, Scott PA, Jenn A, Liu-Bryan R, Glass CK, Neels JG & Olefsky JM. A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways. Journal of Biological Chemistry 2007 282 35279-35292. (doi:10.1074/jbc.M706762200)
38. Varma V, Yao-Borengasser A, Rasouli N, Nolen GT, Phanavanh B, Starks T, Gurley C, Simpson P, McGehee RE Jr, Kern PA &Peterson CA. Muscle inflammatory response and insulin resistance: synergistic interaction between macrophages and fatty acids leads to impaired insulin action. American Journal of Physiology. Endocrinology and Metabolism 2009 296 E1300-E1310. (doi:10.1152/ajpendo.90885.2008)
39. Alibegovic AC, Hojbjerre L, Sonne MP, van Hall G, Stallknecht B, Dela F & Vaag A. Impact of 9 days of bed rest on hepatic and peripheral insulin action, insulin secretion, and wholebody lipolysis in healthy young male offspring of patients with type 2 diabetes. Diabetes 2009 58 2749-2756. (doi:10.2337/db09-0369)
40. Alibegovic AC, Hojbjerre L, Sonne MP, van Hall G, Alsted TJ, Kiens B, Stallknecht B, Dela F & Vaag A. Increased rate of whole body lipolysis before and after 9 days of bed rest in healthy young men born with low birth weight. American Journal of Physiology. Endocrinology and Metabolism 2010 298 E555-E564. (doi:10.1152/ajpendo.00223.2009)
41. Sonne MP, Hojbjerre L, Alibegovic AC, Vaag A, Stallknecht B &Dela F. Diminished insulin-mediated forearm blood flow and muscle glucose uptake in young men with low birth weight. Journal of Vascular Research 2010 47 139-147. (doi:10.1159/000235968)
42. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, Ridderstrale M, Laurila E, Houstis N, Daly MJ, Patterson N, Mesirov JP, Golub TR, Tamayo P, Spiegelman B, Lander ES, Hirschhorn JN, Altshuler D & Groop LC. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nature Genetics 2003 34 267-273. (doi:10.1038/ng1180)
43. Di Gregorio GB, Yao-Borengasser A, Rasouli N, Varma V, Lu T, Miles LM, Ranganathan G, Peterson CA, McGehee RE & Kern PA. Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone. Diabetes 2005 54 2305-2313. (doi:10.2337/diabetes.54.8.2305)
44. Bruun JM, Helge JW, Richelsen B & Stallknecht B. Diet and exercise reduce low-grade inflammation and macrophage infiltration in adipose tissue but not in skeletal muscle in severely obese subjects. American Journal of Physiology. Endocrinology and Metabolism 2006 290 E961-E967. (doi:10.1152/ajpendo.00506.2005)
45. Kunz-Schughart LA, Weber A, Rehli M, Gottfried E, Brockhoff G, Krause SW, Andreesen R & Kreutz M. The "classical" macrophage marker CD68 is strongly expressed in primary human fibroblasts. Verhandlungen der Deutschen Gesellschaft für Pathologie 2003 87 215-223.
46. Hermann TS, Rask-Madsen C, Ihlemann N, Dominguez H, Jensen CB, Storgaard H, Vaag AA, Kober L & Torp-Pedersen C. Normal insulin-stimulated endothelial function and impaired insulin-stimulated muscle glucose uptake in young adults with low birth weight. Journal of Clinical Endocrinology and Metabolism 2003 88 1252-1257. (doi:10.1210/jc.2002-021550)
47. Huber J, Kiefer FW, Zeyda M, Ludvik B, Silberhumer GR, Prager G, Zlabinger GJ & Stulnig TM. CC chemokine and CC chemokine receptor profiles in visceral and subcutaneous adipose tissue are altered in human obesity. Journal of Clinical Endocrinology and Metabolism 2008 93 3215-3221. (doi:10.1210/jc.2007-2630)
48. Lloyd PG, Prior BM, Yang HT & Terjung RL. Angiogenic growth factor expression in rat skeletal muscle in response to exercise training. American Journal of Physiology. Heart and Circulatory Physiology 2003 284 H1668-H1678.
49. Sell H & Eckel J. Monocyte chemotactic protein-1 and its role in insulin resistance. Current Opinion in Lipidology 2007 18 258-262. (doi:10.1097/MOL.0b013e3281338546)
50. Sourris KC, Lyons JG, de Courten MP, Dougherty SL, Henstridge DC, Cooper ME, Hage M, Dart A, Kingwell BA, Forbes JM & de Courten B. JNK activity in subcutaneous adipose tissue but not NFκB activity in peripheral blood mononuclear cells is an independent determinant of insulin resistance in healthy individuals. Diabetes 2009 58 1259-1265. (doi:10.2337/db08-1725)
51. Itani SI, Ruderman NB, Schmieder F & Boden G. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IκB-α. Diabetes 2002 51 2005-2011. (doi:10.2337/diabetes.51.7.2005)
52. Madonna R, Massaro M, Pandolfi A, Consoli A & De Caterina R. The prominent role of p38 mitogen-activated protein kinase in insulin-mediated enhancement of VCAM-1 expression in endothelial cells. International Journal of Immunopathology and Pharmacology 2007 20 539-555.
53. Bertrand F, Philippe C, Antoine PJ, Baud L, Groyer A, Capeau J &Cherqui G. Insulin activates nuclear factor κB in mammalian cells through a Raf-1-mediated pathway. Journal of Biological Chemistry 1995 270 24435-24441. (doi:10.1074/jbc.270.41.24435)
54. Hojbjerre L, Sonne MP, Alibegovic AC, Nielsen NB, Dela F, Vaag A, Bruun JM & Stallknecht B. Impact of physical inactivity on adipose tissue low-grade inflammation in first-degree relatives of type 2 diabetic patients. Diabetes Care 2011 34 2265-2272. (doi:10.2337/dc11-0631)